Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00903890 · ClinicalTrials.gov registry record
Cardiac Effects in Long-Term Survivors of Hodgkin's and Non-Hodgkin's Lymphoma
A clinical trial, sponsored by University of Rochester.
- Completed
- Registry status
- 32
- Enrollment target
NCT00903890: Completed study, sponsored by University of Rochester.
NCT00903890 is a clinical trial that has completed, run by University of Rochester. The registered enrollment target is 32 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00903890 has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- 32 participants
- Enrollment target
Study Summary
This study is to inquire by mailed survey regarding the cardiac and general health of patients previously treated for Hodgkin's and non-Hodgkin's lymphoma with radiation therapy/anthracycline chemotherapy.
Interventions
- OTHER Survey
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2008-08 |
| Est. Completion | 2020-04-09 |
What the finished NCT00903890 record still lists
NCT00903890 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 32 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Survey is the first listed.
NCT00903890 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00903890 about?
NCT00903890 is a clinical study titled "Cardiac Effects in Long-Term Survivors of Hodgkin's and Non-Hodgkin's Lymphoma". This study is to inquire by mailed survey regarding the cardiac and general health of patients previously treated for Hodgkin's and non-Hodgkin's lymphoma with radiation therapy/anthracycline chemotherapy.
What is the current status of trial NCT00903890?
This trial is currently completed. The enrollment target is 32 participants. The study started on 2008-08. Estimated completion is 2020-04-09.
What interventions are being tested in trial NCT00903890?
The interventions under investigation include: Survey (OTHER).
Who is sponsoring clinical trial NCT00903890?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02445781 · 32 participants · Early Phase 1
Differing Levels of Hypoglycemia
- NCT02792270 · 32 participants · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia